Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $7.1800 (-2.78%) ($7.1800 - $7.1800) on Thu. Feb. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.32% (three month average) | RSI | 66 | Latest Price | $7.1800(-2.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2% a day on average for past five trading days. | Weekly Trend | CAPR advances 6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EMHY(76%) IVE(62%) SPY(72%) XLK(62%) FXI(61%) | Factors Impacting CAPR price | CAPR will decline at least -3.66% in a week (0% probabilities). OIH(1%) UNG(7%) TBT(-11%) SIL(8%) VXX(-25%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.66% (StdDev 7.32%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.4(-2.97%) | 10 Day Moving Average | $7.44(-3.49%) | 20 Day Moving Average | $6.92(3.76%) | To recent high | -9.6% | To recent low | 36.8% | Market Cap | $141m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |